Thursday, Nov. 8, 2018 – ASPO Global Cancer Research SIG webinar:
Cancer Epidemiology in Global and Underserved U.S. Settings: Challenges and Opportunities for Research and Training
Click here to view the webinar.
Date/Time: Nov. 8, 2018 Noon (EST)
Presenter: Amr Soliman, PhD, The City College of New York
Dr. Soliman’s research is focused on investigating causes and risk factors of cancer and how that could help in cancer prevention and control, with emphasis on breast, colon and pancreatic cancers. By studying the similarities of cancer epidemiology in developing countries and minority communities in the US, Dr. Soliman hopes to improve our understanding of cancer prevention and control. Contact email@example.com with any questions.
Monday, Nov. 20, 2017 – International Issues in Cancer SIG Webinar:
Programs, and Initiatives for Global Cancer Research at the National Cancer Institute
Click here to view the Webinar:
Date/Time: Nov. 20, 1:30-2:30 p.m. (EST)
Speaker: Dr. Ted Trimble, MD, MPH. Director, NCI Center for Global Health
Bio: Dr. Trimble was appointed as the Director of the NCI CGH in 2011, and oversees the objectives of the center which are to create sustainable international partnerships, support programs that address global gaps in research and scientific training, and disseminate information and best practices that drive improvements in cancer research and cancer control. Between 1991 and 2011, Dr. Trimble was head of NCI’s Gynecologic Cancer Therapeutics where he spearheaded the development of national and international cancer research strategy for the treatment of cervical, ovarian, and endometrial cancers. During that time, he was also Head of NCI’s Quality of Cancer Care Therapeutics, Clinical Investigation Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis. He led the planning committees for NIH Consensus Conferences on ovarian and cervical cancers and also drafted and coordinated NCI Clinical Announcements regarding chemoradiation for cervical cancer in 1999 and intraperitoneal chemotherapy for ovarian cancer in 2008.
Dr. Trimble graduated from Harvard College and the Johns Hopkins University of School of Medicine, then trained in obstetrics/gynecology at Vanderbilt University Medicine Center, public health at the Johns Hopkins University Bloomberg School of Public Health, and gynecologic oncology at Memorial Sloan-Kettering Cancer Center. He has received two Public Health Service Commendation Medals, six NIH Merit Awards, and the NCI Director’s Gold Star Award for his work at NCI.
Contact firstname.lastname@example.org with questions.